Status: awaiting_review. Rule: atlas-profile-2.0.
12 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).
rCBV is the most reproducible advanced marker; consensus acquisition/postprocessing (leakage correction, normalization) enables standardized thresholds
Absolute thresholds vary with preload, echo, leakage-correction, and normalization ROI; multi-echo and standardization studies show persistent site dependence
Whether rCBV can serve as a decision-grade biomarker rather than a supportive one
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.